Krishna Institute of Medical Sciences Limited (KIMS)
Krishna Institute of Medical Sciences Limited (KIMS) is one of the largest healthcare groups in AP and Telangana. KIMS provides multi-disciplinary healthcare services with a key focus on primary, secondary, & tertiary care in tier 2-3 cities. The company offers a comprehensive range of healthcare services including oncology, cardiac sciences, neurosciences, gastric sciences, orthopaedics, renal sciences, organ transplantation, and mother & childcare. As of March 31, 2021, it operates through 9 multi-speciality hospitals with an aggregate bed capacity of 3,064 beds including over 2,500 operational beds.Total Asset of the company increased from Rs 1195.89 crore in FY-2019 to Rs 1436.15 crore in FY-2020 with the increase of 20%. Total revenue of the company reached Rs 1340.10 Crore in FY-2020 from Rs 1128.72 crore in FY-2019 with the growth of 15.77%. Net profit earned by the company in FY-2020 is Rs 205.47 crore.In Fiscal Years 2021 and 2020, KIMS Corporate Social Responsibility expenditure was ₹ 25.58 million and ₹ 16.34 million, respectively, which were primarily applied towards literacy and quality education through Teach for Change trust and towards medical research through KFRC, respectively.Krishna Institute of Medical Sciences Limited has commenced its ₹2143.74 crore initial public offering (IPO), with the price band fixed at ₹815-825 per share and it will be open for subscription till June 18. Each lot consists of 18 shares, so each lot will be worth ₹14,850.Investors, Promoters and 40 other persons have liquidated several shares for IPO. Investors have liquidated 16,003,615 shares. In promoters, Dr. Bhaskara Rao Bolleneni has liquidated 387966 shares, Rajyasri has liquidated 775933 shares and BRMH has liquidated 387966 shares. Other 40 individuals have liquidated 6005058 shares.Due to current pandemic, the healthcare sector is demanding huge investment. This is primarily due to low healthcare expenditure in India in past years. These investments will prove to be a boon for the healthcare sector. KIMS can most likely see listing games due to more expenditure in public health spending to overcome any future global crisis and be ready to fight any future pandemic.
